2009 Program and Abstracts

At the conclusion of this presentation the participant will be able to:
• Identify and suggest treatment options for patients with superior vena caval syndrome.
• Identify patients with subclavian vein thrombosis and stenosis.
• Identify the use of lytic and mechanical thrombectomy for ileofemoral thrombosis and stenosis as well as the potential use of stents and angioplasty for the treatment of ileofemoral stenosis occlusion. 
• Recognize, diagnose, and suggest diagnostic and treatment algorithm for patients with pelvic venous congestion. 
• Identify treatment options for vena caval tumors.
• Define which patients are potential candidates for retrievable filters and whether retrievable filter is indicated or a permanent filter should be selected.
• Identify the appropriate treatment for SVT in a variety of clinical scenarios. 

Faculty: 
“Superior Vena Caval Syndrome”
Amy B. Reed, MD; Cincinnati, OH

“Subclavian Vein Thrombosis and Stenosis”
Joseph J. Ricotta, MD, Stony Brook, NY

“Illiofemoral Venous Thrombosis”
Ruth L. Bush, MD; Temple, TX

“Role of Venous Stenting in Iliac-Femoral Occlusion / Stenosis”
Seshadri Raju, MD; Flowood, MS

“Pelvic Venous Congestion Syndrome”
Mark H. Meissner, MD; Seattle, WA

“Vena Caval Tumors”
Kenneth J. Cherry Jr., MD; Charlottesville, VA

“Filters, Retrievable; Fact or Fiction”
Kristen Biggs, MD; Albuquerque, NM

“SVT, Not all one disease”
Joann M. Lohr, MD; Cincinnati, OH

“Recurrent Varicose Veins, What can be done”
Kellie R. Brown, MD; Milwaukee, WI

SCIENTIFIC SESSION 1 – LE

Moderated by: Richard Neville, MD & George H. Meier, III, MD

Learning Objectives:
• Recognize the evolving role of novel endovascular, hybrid and imaging techniques in the management of lower extremity occlusive disease.
• Understand recent trends and identify opportunities to improve outcomes in the management of lower extremity obstructive disease
• Describe the current status of primary care screening for lower extremity occlusive diseas

1. Role of Simple and Complex Hybrid Revascularization Procedures for Symptomatic Lower Extremity Occlusive Disease
Hasan H. Dosluoglu, MD¹, Purandath Lall, MBB¹, Gregory S. Cherr, MD², Linda M. Harris, MD², Maciej L. Dryjski, MD²; ¹A Western NY Healthcare System, SUNY at Buffalo, Buffalo, NY, USA, ²SUNY at Buffalo, Buffalo, NY, USA.

2. Cryoplasty for Lower Extremity Arterial Occlusive Disease: Is the Outcome Worth the Price Tag?
Megan Carroll, BS BA , Japa A. Volchok, DO, Greg C. Schmieder, MD, Jean M. Panneton, MD; Eastern Virginia Medical School, Norfolk, VA, USA. Elie S. Semaan, MD , Naomi Hamburg, MD, Wael Nasr, MD, Palma Shaw, MD, Kathryn Collins, MD, Robert Eberhardt, MD, Jonathan Woodson, MD, Alik Farber, MD; Boston University Medical Center, Boston, MA, USA.

3. Endovascular Management of the Poplieal Artery:
Comparison of of Atherectomy and Angioplasty
Elie S. Semaan, MD , Naomi Hamburg, MD, Wael Nasr, MD, Palma Shaw, MD, Kathryn Collins, MD, Robert Eberhardt, MD, Jonathan Woodson, MD, Alik Farber, MD; Boston University Medical Center, Boston, MA, USA.

4. Microdissection and Re-entry Devices: Limitations, Application & Utility
Anil Hingorani, MD, Enrico Ascher, MD, Natalie Marks, MD RVT, Alexander Shiferson, DO, Nirav Patel, DO, Kapil Gopal, MD, Theresa Jacob, PhD; Maimonides Medical Center, Brooklyn, NY, USA.

5. Achieving The Goal Of Below Knee Amputation: An Argument For Strict Case Selection
Steven C. Agle, MD, MPH , Michael M. McNally, MD, Sheila K. Kori, William F. Curry, Christopher I. Jones, Frank M. Parker, DO, William M. Bogey, Jr., MD, C. Steven Powell, MD, Michael C. Stoner, MD; Brody School of Medicine, East Carolina University, Greenville, NC, USA.

MP1. National Outcomes of Endovascular and Open Reinterventions of Lower Extremity Bypass Graft Repair
Ami D. Jhaveri, MD , Allen Hamdan, MD, Frank Pomposelli, MD, Kristina Giles, MD, Mark C. Wyers, MD, Marc L. Schermerhorn, MD; Beth Israel Deaconess Medical Center, Boston, MA, USA.

MP2. Factors Associated With Survival Following Lower Extremity Bypass In Northern New England
Philip P. Goodney, MD , Brian C. Nolan, MD, Andrew C. Stanley, MD, Daniel J. Bertges, MD, Jens Eldrup-Jorgensen, MD, Donald S. Likosky, PhD, Jack L. Cronenwett, MD; Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

MP3. Five Years Prospective study of Duplex Ultrasound Arterial Mapping (DUAM) as a primary modality in management of Critical lower limb ischemia (CLI). Technical and clinical outcome after Bypass Surgery (BS) and Endovascular Revascularisation (EvR)
Chris Beirne, MB BCh MRCSI , Sherif Sultan, MD FRCSI DEVS EBQS – VASC; Western Vascular Institute, Galway, Ireland.

MP4. Screening for Peripheral Artery Disease Among Primary Care Physicians
Andrew Dueck , Douglas Wooster, Elizabeth Wooster; University of Toronto, Toronto, ON, Canada

DEDICATED HANDS-ON SESSION
(Exhibits & Stations available)

SCIENTIFIC SESSION 2 - AORTIC 1

Moderated by: Alan B. Lumsden, MD & Matthew Dougherty, MD

Learning Objectives:
• Describe recent trends and identify opportunities to improve outcomes for aortic aneurysm and dissection
• Recognize evolving technical considerations and physiologic factors that may improve outcomes for EVAR and TEVAR
• Describe recent trends in management and outcomes for ruptured abdominal and thoracic aortic aneurysm

6. 5 Year Follow Up Of The Talent eLPS Abdominal Stent Graft Pivotal Trial: Early And Long Term Safety And Efficacy
Irene C. Turnbull, MD , Mikel Sadek, MD, Honesto Poblete, MD, Jonathan Bowman, MD, Rajesh Malik, MD, Alexander Salloum, MD, Angeliki G. Vouyouka, MD, Sharif H. Ellozy, MD, Michael L. Marin, MD, Peter L. Faries, MD; Mount Sinai School of Medicine, New York, NY, USA.

7. Hybrid Thoracic Endovascular Aortic Repair (TEVAR): Are We Pushing The Envelope Too Far?
Houssam K. Younes, MD¹, Kristofer M. Charlton-Ouw, MD¹, Patricia W. Harris, B², Jean Bismuth, MD¹, Joseph J. Naoum, MD¹, Imran T. Mohiuddin, MD¹, Mark G. Davies, MD, PhD¹, Eric K. Peden, MD¹, Michael J. Reardon, MD¹, Alan B. Lumsden, MD¹; 1Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, TX, USA, ²he Methodist Hospital Research Institute, The Methodist Hospital, Houston, TX, USA.

8. How often are ruptured abdominal aortic aneurysms suitable for endovascular repair?
Manish Mehta, MD , John B. Taggart, MD, Stephanie Saltzberg, MD, Paul B. Kreienberg, MD, Sean P. Roddy, MD, Philip Sk Paty, MD, Yaron Sternbach, MD, Kathleen J. Ozsvath, MD, Dhiraj M. Shah, MD, R. Clement Darling, III, MD; Albany Medical College, Albany, NY, USA.

9. A 15 year Comparative Analysis of Open and Endovascular Repair for the Ruptured Descending Thoracic Aorta
Himanshu J. Patel, MD , David M. Williams, MD, Gilbert R. Upchurch, MD, G. Michael Deeb, MD; University of Michigan Hospitals, Ann Arbor, MI, USA.

10. The Impact of Obesity on Perioperative Outcomes of Open and Endovascular Abdominal Aortic Aneurysm Repair from the National Surgical Quality Improvement Program
Kristina A. Giles, MD. , Frank B. Pomposelli, Jr., MD., Allen D. Hamdan, MD., Mark C. Wyers, MD., Marc L. Schermerhorn, MD; Beth Israel Deaconess Medical Center, Boston, MA, USA.

MP5. Outcomes of elective surgery in Chronic Type B Aortic Dissection Girma Tefera,
John Hoch, MD, Mathew Mell, MD, Charles Acher; University of Wisconsin Medical School, Madison, WI, USA.

MP6. Celiac Artery Interaction in Thoracic Endovascular Aneurysm Repair
Clayton J. Brinster, MD , Ronald M. Fairman, MD, Wilson Y. Szeto, MD, Edward Y. Woo, MD, Alberto Pochettino, MD, Jeffrey P. Carpenter, MD, William Moser, BSN, RN, Joseph E. Bavaria, MD, Benjamin M. Jackson, MD; Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

MP7. Effect of Early Plasma Transfusion on Survival in Patients with Ruptured Abdominal Aortic Aneurysm
Matthew W. Mell, MD , Amy Schmidt, BS, William D. Turnipseed, MD, John R. Hoch, MD, Girma Tefera, MD, Charles W. Acher, MD; University of Wisconsin, Madison, WI, USA.

MP8. Does intentional accessory renal artery occlusion during Endovascular Abdominal Aneurysm Repair affect outcomes?
Rafael D. Malgor, MD , Joseph J. Ricotta, MD, Gustavo S. Oderich, MD, Manju Kalra, MBBS, Audra A. Duncan, MD, Thomas C. Bower, MD, Peter Gloviczki, MD; Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, Rochester, MN, USA.

DEDICATED HANDS-ON SESSION
(Exhibits & Stations available)

COOK FELLOWLUMINARIES PROGRAM - Part I
(Reception and Working Dinner)

WELCOME RECEPTION IN EXHIBIT HALL

SPECIAL INTEREST GROUP (SIG) BREAKFAST SESSIONS

SIG 1: Difficult Aortic Endografts
Moderators: O. William Brown, MD & Samuel R. Money, MD
Supported by Cook, Inc.

SIG 2: Issues in Dialysis Access
Moderator: Alan M. Dietzek, MD

Exhibit Hall Hours

Registration Desk

Speaker Ready Room

Continental Breakfast with Industry

SCIENTIFIC SESSION 3 - AORTIC II

Moderated by: Michel S. Makaroun, MD & Gilbert Upchurch, MD

Learning Objectives:
• Describe recent trends in outcomes for open and endvascular repair of abdominal and thoracic aortic aneurysm
• Recognize evolving strategies to improve treatment planning, technical success and optimize surveillance for EVAR and TEVAR
• Identify factors associated with improved outcomes in patients with emergent or complex aortic aneurysm diseas

11. Treatment options for delayed AAA rupture following endovascular repair: Outcomes of a prospective analysis
Manish Mehta, MD , R. Clement Darling, III, MD, Sean P. Roddy, MD, Philip Sk Paty, MD, John B. Taggert, MD, Yaron Sternbach, MD, Kathleen J. Ozsvath, MD, Paul B. Kreienberg, MD, Benjamin B. Chang, MD, Dhiraj M. Shah, MD; Albany Medical College, Albany, NY, USA.

12. Early Outcomes of Endovascular versus Open Thoracic Aortic Aneurysm Repair in the National Surgical Quality Improvement Program (NSQIP)
Mark F. Conrad, MD, Robert T. Lancaster, MD, Ugwuji N. Maduekwe, MD, Matthew Hutter, MD, Christopher J. Kwolek, MD, Richard P. Cambria, MD; Massachusetts General Hospital, Boston, MA, USA.

13. Endovascular Repair of Infrarenal Abdominal Aortic Aneurysms Based on Size: Comparison of Patient Outcomes Using Modular Stent Graft Designs
Michael J. Gaffud, MD, Marc A. Passman, MD , Christopher J. LeCroy, MD, Mark A. Patterrson, MD, Steven M. Taylor, MD, Bart R. Combs, MD, William D. Jordan, MD; University of Alabama at Birmingham, Birmingham, AL, USA.

14. ICU Admission APACHE III Score Predicts Hospital Mortality in Thoracoabdominal Aneurysms (TAAA) repair and Abdominal Aortic Aneurysms (AAA) repair
Loay Kabbani , Brian Knipps, Guillermo Escobar, Frank Vandy, Peter Henke, Lena Napolitano, Gilbert Upchurch; University of Michigan, Ann Arbor, MI, USA.

15. Duplex Ultrasonography Alone is Sufficient For Mid-Term EVAR Surveillance: A Prospective Cost-Analysis Study
Brian R. Beeman, MD., Lynne Doctor, BA, Matthew J. Dougherty, MD, Kevin Doerr, RVT, Sandy McAfee-Bennett, RVT, Keith D. Calligaro, MD; Pennsylvania Hospital, Philadelphia, PA, USA.

MP9. EVAR vs. Open Surgery for Ruptured Abdominal Aortic Aneurysms
Mohsen Bannazadeh, MD , Timur Sarac, MD, Flynn Rowan, Vikram Kashyap, MD, James Bena, Daniel Clair, MD; Cleveland Clinic, Cleveland, OH, USA.

MP10. Early and Late outcomes of open thoracoabdominal aortic aneurysm repair in patients younger than 50 years
Nanette R. Reed, MD , Manju Kalra, MBBS, Cornelius Groenewald, MBChB, Thoralf Sundt, III, MD, Thomas Bower, MD, Audra Duncan, MD, Gustavo Oderich, MD, Joseph Ricotta, MD, Peter Gloviczki, MD; Mayo Clinic-Rochester, MN, Rochester, MN, USA.

MP11. Thoracic Endovascular Aortic Repair of Aortobronchial Fistulas
James D. Brooks, MD; UNC School of Medicine, Chapel Hill, NC, USA.

MP12. EVAR Using an Anatomical Fixation Technique and Concomitant Suprarenal Orientation: Results of a Prospective, Multicenter Trial
Stuart Harlin, MD, FACS; Sacred Heart Medical Center, Pensacola, FL, USA.

DEDICATED HANDS-ON SESSION
(Exhibits & Stations available)

SCIENTIFIC SESSION 4 – DIALYSIS

Moderated by: Joann M. Lohr, MD & Anil Hingorani, MD

Learning Objectives:
• Describe recent trends in outcomes for arterivenous access procedures
• Recognize evolving strategies to improve treatment planning for arteriovenous access procedures
• Identify novel strategies to enhance outcomes for arteriovenous access procedures in patients with challenging venous anatomy

16. Comparison of the Efficacy of Upper Arm Transposed Arteriovenous Fistulae and Upper Arm Prosthetic Grafts: Analysis of 358 Matched Procedures
Karen Woo¹, Tina Ng², Gheorghe Doros, PhD³, Alik Farber³; ¹Scripps/UCSD, La Jolla, CA, USA, ²Cedars-Sinai Medical Center, Los Angeles, CA, USA, ³Boston University, Boston, MA, USA.

17. Upgrading Small Caliber Veins (< 3mm) for Arteriovenous Fistulas: Primary Balloon Angioplasty plus Balloon Angioplasty Maturation
Lorena P. De Marco Garcia, MD , Luis R. Davila-Santini, MD, Feng Qin, MD, Julio Calderin, MD, Kambhampaty Krishnasastry, MD, Thomas Panetta, MD; North Shore LIJ Health System, Manhasset, NY, USA.

MP13. Frequency And Importance Of Variant Brachial-Basilic Vein Anatomy: An Observational Study Using Doppler Ultrasound Vein Mapping
Houssam K. Younes, MD¹, Christy L. Kaiser, BS² , Debra L. Canter, BA², Kristofer Charlton-Ouw, MD¹, Mark G. Davies, MD,PhD¹, Alan B. Lumsden, MD¹, Eric K. Peden, MD¹ ; ¹Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, TX, USA, ²The Methodist Hospital Research Institute, The Methodist Hospital, Houston, TX, USA.

MP14. Hemoaccess Placement in patients with Challenging Central Vein Occlusion
Chris Stout, MD, Jean Panneton, MD, Marc H. Glickman, MD. Eastern Virginia Medical, Norfolk, VA, USA.

MP15. Preoperative Vein Mapping for Hemodialysis Access: Is It Beneficial?
Christopher J. Barreiro, MD, Sumeska Thavarajah, MD, Thomas Reifsnyder, MD; Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.

Introduction of Distinguished Visiting Professor

Distinguished Visiting Professor:

J. Michael Bacharach, MD, MPH, FACC
North Central Heart Institute Sioux Falls, South Dakota
"Evolution of Vascular Care: Collaboration or Competition"

Society for Vascular Medicine (SVM) Scientific Session:

John R. Bartholomew, MD
Cleveland Clinic, Cleveland, Ohio
"Heparin Induced Thrombocytopenia and the Vascular Surgeon"

Jeffrey Olin, MD
Cleveland Clinic, Cleveland, Ohio
"Contemporary Management of Fibromuscular Dysplasia"

CONCURRENT LUNCHEON SYMPOSIA
(including boxed lunch)

• Symposia 1: Endologix, Inc
“Strategies for Successful Endovascular Treatment of the Challenging AAA Neck”
Speakers:
Jeffery P. Carpenter, MD, Cooper University Hospital, Camden, NJ
William D. Jordan, MD, UAB Hospital, Birmingham, AL

• Symposia 2: Gore & Assocites Title: TBD

• Symposia 3: TBD Title: TBD

GOLF OUTING & FREE AFTERNOON
Jacaranda Golf Course

COOK FELLOWLUMINARIES PROGRAM - Part II
Lunch and Program

SCVS VASCULAR TOP GUN PROGRAM
Supported by Boston Scientific and Gore & Associates

SCVS YOUNG VASCULAR SURGEONS DINNER SYMPOSIUM
Supported by Medtronic, Inc.

SPECIAL INTEREST GROUP (SIG) BREAKFAST SESSIONS

SIG 1 Challenging Cases I Wish I Hadn’t Done
Moderator: Alan B. Lumsden, MD & Michel S. Makaroun, MD
Supported by Medtronic, Inc.

SIG 2 Wound Care Management
Moderator: David Steed, MD

Exhibit Hall Hours

Registration Desk 

Speaker Ready Room

Continental Breakfast with Industry

SCIENTIFIC SESSION 5 - CAROTID

Moderated by: Keith Calligaro, MD & Robert McLafferty, MD

Learning Objectives:
• Describe recent trends in management, outcomes and costs in the management of carotid artery obstructive disease
• Identify evolving trends in treatment planning, technical approaches and monitoring strategies in patients undergoing carotid angioplasty and stent procedures
• Describe phenotypic and physiologic factors associated with improved outcomes for carotid artery obstructive disease

18. Is CAS Being Performed Preferentially in High Risk Surgical Patients?
Jason T. Lee, MD , Tom C. Nguyen, MD, Mediget Teshome, MD, Mary Qiu, BS, Shyam Raghavan, BS, Ronald L. Dalman, MD, John Morton, MD; Stanford University Medical Center, Stanford, CA, USA.

19. An Analysis of 4001 Carotid Artery Stenting Procedures Performed in New York and Florida (2005-2006): Procedure Indication, Stroke Rate, and Mortality are Equivalent for Vascular Surgeons and Non-Vascular Surgeons
Robert C. Steppacher, Jr., MD , Nicholas Csikesz, BA, Mohammad H. Eslami, MD, Elias Arous, MD, Louis M. Messina, MD, Andres Schanzer, MD; University of Massachusetts, Worcester, MA, USA.

20. Responsivity to Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
John Blebea, MD , John Wang, MD, Michael Salvatore, BS, Patricia McNelis; Temple University, Philadelphia, PA, USA.

21. Carotid Artery Stenting in the Nation: The Influence of Hospital and Physician Volume on Outcomes
Todd R. Vogel, MD, MPH , Viktor Y. Dombrovskiy, MD PhD MPH, Paul B. Haser, MD, Alan M. Graham, MD; UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

22. Predictors of Clinically Significant Post-Procedure Hypotension Following Carotid Endarterectomy and Carotid Angioplasty with Stenting
Brian D. Park, MD , Olga Madej, MSIII, Caitlin McPhelimy, BA, Bryan Piccirillo, MSIII, Michael S. Dahn, MD, PhD, Joseph A. Burleson, PhD, James O. Menzoian, MD; University of Connecticut, Farmington, CT, USA.

MP16. A simplified approach to velocity criteria in the duplex ultrasound diagnosis of asymptomatic carotid artery stenosis
Firas F. Mussa, MD , David Cheever, B.A, Victoria Lee, B.A, Caron B. Rockman, MD, Thomas S. Riles, MD; New York University School of Medicine, New York, NY, USA.

MP17. Gender Impact on Clinical Outcomes After Endovascular and Open Carotid Interventions: Analysis of 645 Procedures
Habib U. Khan, MD¹, Bing Xia, BA¹, Lee J. Goldstein, MD¹, Harry L. Bush, MD¹, John Karwowski, MD¹, Peter L. Faries, MD², K. Craig Kent, MD¹ , Ageliki G. Vouyouka, MD¹ ; ¹New York Presbyterian Hospital, New York, NY, USA, ²Mount Sinai Medical Center, New York, NY, USA

MP18. Cost Analysis of Carotid Endarterectomy and Stenting
M. Ashraf Mansour, MD., B Seth DeCamp, MD , Jason D. Slaikeu, MD, Chris M. Chambers, MD, Jill M. Gorsuch, MD; Spectrum Health, Grand Rapids, MI, USA.

MP19. Regional Variation across the United States in the Management of Carotid Artery Disease
Todd R. Vogel, MD, MPH , Viktor Y. Dombrovskiy, MD, MPH, PhD, Paul B. Haser, MD, Alan M. Graham, MD; UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

DEDICATED HANDS-ON SESSION
(Exhibits & Stations available)

International Panel
Jonothan Earnshaw, MD; Gloucestershire Royal Hospital, United Kingdom
Will Wisselink, MD; VU University Medical Center, Amsterdam, Netherlands
Jacques Bleyn, MD; Antwerp Blood-Vessel Center (ABC), Belgium

Presidential Address:
Alan B. Lumsden, MD

MEMBERS’ BUSINESS LUNCHEON

Networking Lunch (Exhibit Hall)

POSTER COMPETITION, FIRST ROUND
Moderators:  Thomas C. Bower, MD & Alan Dardik, MD

AORTA I

P1 The role of Anatomic factors in Predicting Success of Endovascular Repair of Thoracic Aortic Aneurysms
Jonathan N. Bowman, M.D. , Sharif H. Ellozy, MD, Daniel Silverberg, MD, Victoria Teodorescu, MD, Honesto Poblete, MD, Michael L. Marin, MD, Peter L. Faries, MD. Mount Sinai School of Medicine, New York, NY, USA.

P2 Discrepancies in Perioperative Mortality Definitions After Open and Endovascular Aortic Aneurysm Repair; Evaluation in United States Medicare Beneficiaries
Marc L. Schermerhorn, MD¹ , Kristina A. Giles, MD¹, Allen D. Hamdan, MD¹, Mark C. Wyers, MD¹, Bruce E. Landon, M.D., M.B.A.², Phillip Cotterill, Ph.D³ , A.James O'Malley, Ph.D², Frank B. Pomposelli, Jr., MD¹,  ¹ Beth Israel Deaconess Medical Center, Boston, MA, USA,² Harvard Medical School, Boston, MA, USA,³ Centers for Medicare and Medicaid Services, Baltimore, MD, USA.

P3 Complicated Acute Type B Dissection and Thoracoabdominal Dissecting Aneurysm: Long-term results of surgical aortic conservative treatment.
Santi Trimarchi, MD¹, Valerio Tolva, MD¹, Viviana Grassi, MD¹, Gabriele Bertoni, MD¹ , Gilbert R. Upchurch, Jr., MD² , Vincenzo Rampoldi, MD¹. ¹ Policlinico San Donato IRCCS, San Donato Milanese, Italy, ² University of Michigan Health System, Ann Arbor, MI, USA.

P4 Aorto-Uniliac Vs Bifurcated Endovascular Aortic Repair: Technical Success, Secondary Intervention Rate and Quality-adjusted cost analysis.
Niamh Hynes, MD MRCSI, Sherif Sultan, MD FRCSI DEVS EBQS - VASC. Western Vascular Institute, Galway, Ireland.

P5 The Correlation of Aortic Neck Length and Angle to Early and Late Outcomes in Endovascular Aneurysm Repair (EVAR) Patients.
Ali F. AbuRahma, MD¹, John Campbell, MD¹, Patrick A. Stone, MD¹, Aravinda Nanjundappa, MD¹ , Akhilesh Jain, MD¹, L. Scott Dean, Ph.D, MBA², Joseph Habib, MD¹, Tammi Keiffer, R.N.², Mary Emmett, Ph.D.².  ¹ R C Byrd Health Sc. Center of W. Va. Univ., Charleston, WV, USA,² Charleston Area Medical Center, Charleston, WV, USA.

AORTA II

P6 Comparison Of Ultrasound And Ct Scan Determined Aaa Diameters Following Endovascular Aaa Repair
Sukgu M. Han, M.D. , Kaushal Patel, M.D., Aaron Bond, Ph.D., Sumeet Syan, B.S., Fred Weaver, M.D.. University of Southern California, Los Angeles, CA, USA.

P7 Financial Implications Of Technological Adaptation: The Burden Of Endovascular Aortic Aneurysm Repair Device Cost On Hospital Finances
Michael M. McNally, MD , Steven C. Agle, MD, MPH, Sheila K. Kori, William F. Curry, Christopher I. Jones, Samuel A. Hays, Frank M. Parker, DO, William M. Bogey, Jr., MD, C. Steven Powell, MD, Michael C. Stoner, MD. Brody School of Medicine, East Carolina University, Greenville, NC, USA.

P8 Gender, Racial and Ethnic Differences in Aortic Wall Tension and Prevalence of Aortic Abdominal Aneurysms
Carlos H. Timaran , Eric B. Rosero, MD, Andres Martinez, MD, J Gregory Modrall, MD, G Patrick Clagett, MD. University of Texas Southwestern Medical Center, Plano, TX, USA.

P9 Late Survival of Patients with and without Type II Endoleaks after EVAR
Kevin Bruen, MD, Peter Nelson, MD, Robert Feezor, MD, Thomas Huber, MD, PHD, James Seeger, MD, Anthony Lee, MD. University of Florida, Gainesville, FL, USA.

P10 Post-Endovascular Aneurysm Repair Patient Outcomes And Follow-up Are Not Adversely Impacted By Long Travel Distance To Tertiary Vascular Surgery Centers
Dusadee Sarangarm, M.D., Jordan Knepper, B.S., John Marek, M.D., Kristen L. Biggs, MD , Diane Robertson, R.N., Mark Langsfeld, M.D.. University of New Mexico Health Sciences Center, Albuquerque, NM, USA.

CAROTID

P11 Carotid Angioplasty and Stenting: Worse Neurological Outcome with 2 Stents Versus Single Stent
Christopher L. Stout, MD, Albert I. Richardson, MD, Susanna H. Shin, MD, Rasesh M. Shah, MD, Jean M. Panneton, MD. Division of Vascular Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.

P12 Cerebral Oximetry Can Replace Carotid Artery Stump Pressure Measurements During Endarterectomy
Jee Yeun Lee, George Hines, Martin Feuerman, Alexandra Oleske, Reese Wain. Winthrop University Hospital, Mineola, NY, USA.

P13 Early carotid intervention after acute stroke; early and mid-term results
Panagiotis Kougias, MD , W.F. Johnston, MD, Carlos F. Bechara, MD, Tam T. Huynh, MD, Catherine Cagiannos, MD, Peter H. Lin, MD; Baylor College of Medicine, Houston, TX, USA.

P14 Routine Shunting In Carotid Endarterectomy: Reducing Costs But Not Outcome.
Lorena P. De Marco Garcia, MD , Luis R. Davila-Santini, MD, Julio Calderin, MD, Feng Qin, MD, Richard Schutzer, MS, Kambhampaty Krishnasastry, MD. North Shore LIJ Health System, Manhasset, NY, USA.

P15 A Novel Ex-vivo Model for Carotid Artery Stenting
Paul B. Haser, M.D. , Daniel I. Fremed, B.S., Todd R. Vogel, M.D., Shaohua Li, M.D., Alan M. Graham, M.D.. UMDNJ-RWJMS, New Brunswick, NJ, USA.

P16 Vascular Laboratory Studies - Videotapes are Lost and Duplex Data Inaccurately Reported
Paul Polyak, MD , John Blebea, MD, Patrick Kelly, RVT, John Wang, MD, Eugene Palchik, MD. Temple University, Philadelphia, PA, USA.

DIALYSIS

P17 A Novel Approach for Conversion of Temporary Hemodialysis Catheters to Permanent Catheters without Additional Venous Instrumentation.
Paul B. Haser, MD¹, Albeir Mousa, MD¹, Zafar Jamil, MD², Todd R. Vogel, MD¹, Alan Graham, MD¹. ¹ UMDNJ-RWJMS, New Brunswick, NJ, USA,² St. Michael's Medical Center, Newark, NJ, USA.

P18 Utility of Viabahn Stent-Grafts in Improving the Secondary Patency of Hemodialysis Arteriovenous Grafts
Luis R. Davila-Santini, MD , Feng Qin, MD, Kambhampaty V. Krishnasastry, MD, Toufic K. Safa, MD. North Shore-LIJ Health System, New York, NY, USA.

P19 The Implications of Acute Anatomic Injury after Percutaneous Renal Angioplasty and Stenting.
Mark G. Davies, MD PhD MBA , Jean X. Bismuth, MD, Joseph J. Naoum, MD, Imran T. Mouhiddin, MD, Eric K. Peden, MD, Alan B. Lumsden, MD. Methodist Debakey Heart and Vascular Center, Houston, TX, USA.

P20 Balloon Angioplasty of venous lesions to facilitate placement of Tunneled Cuffed Catheters for hemodialysis.
Anil Hingorani, M.D. , Enrico Ascher, MD, Natalie Marks, MD RVT, Alexander Shiferson, D.O., Nirav Patel, D.O., Kapil Gopal, MD, Theresa Jacob, PhD. Maimonides Medical Center, Brooklyn, NY, USA.

P21 Arteriovenous Fistula/Graft Salvage Using Suction Assisted Lipectomy
Alanna Rebecca, MD , Daniel Krochmol, MD, Alyssa Chapital, MD, Richard Fowl, MD, William Casey, III, MD, Kristen Kalkbrenner, PAC, Anthony Smith, MD, Money Samuel, MD, William Stone, MD. Mayo Clinic Arizona, Phoenix, AZ, USA.

P22 Right Axillary Lliac graft: Case report with 3 years follow up.
Rajiv K. Chander, MD¹, Fawad Khan, MD¹, Parind M. Oza, M.D¹, Mayank Patel, MD¹ , Nilesh Balar, MD¹, Sushil Gupta, M.D². ¹Montifiore North, Bronx, NY, USA,² Robert Packer Hospital, Bronx, NY, USA.

LE

P23 The Impact of Obesity on Outcome Following Infrainguinal Arterial Bypass
Garth S. Herbert, MD , Matthew J. Martin, MD, Charles A. Andersen, MD, Niten Singh, MD. Madigan Army Medical Center, Tacoma, WA, USA.

P24 Obturator Bypass for Complicated Femoral Infections: A Single Center Experience
Carlos Rosales, MD , Charles Crafton, PAC, Amy B. Reed, MD, Joseph S. Giglia, MD. University of Cincinnati College of Medicine, Cincinnati, OH, USA.

P25 Gender Differences in the Outcome of Endovascular Intervention (EVI) on Infrainguinal Arteries in the Critically Ischemic Limb
Joseph Andrews, BS , Linda M. Harris, MD, Monica O'Brien-Irr, MS, RN, Hasan Dosluoglu, MD, Gregory Cherr, MD, Maciej Dryjski, MD, PhD.  State University of New York at Buffalo, Buffalo, NY, USA.

P26 Outcomes of Infrapopliteal Percutaneous Transluminal Angioplasty and Stenting for Critical Limb Ischemia
Jean-Paul LeFave, MS , Romeo B. Mateo, MD, Anthony L. Pucillo, MD, Arun M. Goyal, MD, Pravin M. Shah, MD, Sateesh C. Babu, MD, Igor A. Laskowski, MD. New York Medical College, Westchester Medical Center, Valhalla, NY, USA.

P27 Endovascular Techniques to Improve the Management of Thrombosed Lower Extremity Prosthetic Bypasses
Neal S. Cayne, MD¹, Frank J. Veith, MD¹, Evan Lipsitz, MD², Steve Bauer, MD³. ¹NYU Medical Center, New York, NY, USA, ² Montefiore, New York, NY, USA,³ NYU, New York, NY, USA.

BASIC/OTHER

P28 The Influence of Stents on the Performance of an Ultrasonic Navigational System for Endovascular Procedures
Aaron E. Bond, Ph.D¹, Jay Mung², Sukgu Han, MD¹, Dan Fullerton², Fred A. Weaver, M.D., M.M.M.¹, Jesse T. Yen, Ph.D.².  ¹Division of Vascular Surgery and Endovascular Therapy, Cardiovascular Thoracic Institute, University of Southern California, Los Angeles, CA, USA, ²Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.

P29 Influence of smoking status on death in vascular surgical patients from the national surgical quality improvement program (nsqip) database: is there a “smokers paradox”?
Robert S. Crawford, MD , Christopher J. Abularrage, MD, Mark F. Conrad, MD, Richard P. Cambria, MD, Glenn M. LaMuraglia, MD. Massachussets General Hospital, Boston, MA, USA.

P30 The Second Time Around: Re-Intervention Following Surgical Treatment in Patients with Thoracic Outlet Syndrome
Lisa Rotellini-Coltvet, MA, MMS, PA-C , Emma McDonnell, Julie Freischlag, MD. Johns Hopkins Medical Institutions, Baltimore, MD, USA.

P31 Peripheral Arterial Plaque Classification With Intravascular Ultrasound: A Radiofrequency Data Analysis.
Paul D. Bishop, MSEE , Daniel G. Clair, MD, Lindsay E. Feiten, BS, Vikram S. Kashyap, MD. Cleveland Clinic, Cleveland, OH, USA.

P32 Arterial Thoracic Outlet Syndrome Presents with Acute Ischemia in Young Women
Katherine A. Gallagher, M.D. , Julie Freischlag. Johns Hopkins University, Baltimore, MD, USA.

VENOUS/VISERAL

P33 Clinical Outcome and Quality of Life after surgical treatment for Klippel-Trinaunay Syndrome: A case-control study
Rafael D. Malgor, MD , Peter Gloviczki, MD, Manju Kalra, MBBS, Gustavo S. Oderich, MD, Joseph J. Ricotta, MD, Stephen S. Cha, MS, David Driscoll, MD, Terri Vrtiska, MD, Audra A. Duncan, MD. Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, Rochester

P34 The role of routine IVC/Iliac vein and Infra-popletial venous duplex scans
Saadi Alhalbouni, MD, Anil Hingorani, MD, Enrico Ascher, MD, Natalie marks, MD RVT, Alexander Shiferson, DO, Nnirav Patel, DO, Kapil Gopal, MD, Theresa Jacob, PhD. Maimonides Medical Center, Brooklyn, NY, USA.

P35 Experience with Over 100 Consecutive Powered Phlebectomies: Too Many or Not Enough?
Jennifer A. Heller, MD FACS . Johns Hopkins, Baltimore, MD, USA.

P36 - Withdrawn 

P37 Retrograde Open Mesenteric Stenting for Acute Mesenteric Ischemia: A Viable Alternative for Emergent Revascularization
Christopher L. Stout, MD , Cory A. Messerschmidt, BS, Gordon K. Stokes, MD, Jean M. Panneton, MD. Eastern Virginia Medical School, Norfolk, VA, USA

P38 Quality of Life Improvement Following Endovascular Treatment of May-Thurner Syndrome
Shyam S. Raghavan, BS , Mediget Teshome, MD, Mary Qiu, BS, Tae K. Song, MD, E. John Harris, MD, Ronald L. Dalman, MD, Jason T. Lee, MD. Stanford University Medical Center, Stanford, CA, USA.

SCIENTIFIC SESSION 6 – OTHER

Moderated by: William Quinones-Baldrich, MD & TBD

Learning Objectives:
• Identify emerging trends in treatment planning, technical approaches and surveillance strategies in the management of lower extremity occlusive disease
• Understand recent trends and identify opportunities to improve outcomes for the endovascular management of lower extremity obstructive disease
• Describe the impact of endovascular training fellowships on vascular practice trend

23. Graft Preservation in Early Groin Infections Using Vacuum-Assisted Closure Without Muscle Flap Coverage: A Consecutive Patient Series.
Hasan H. Dosluoglu, MD¹, Cyrus Logmanee, MD² , Purandath Lall, MBBS¹, Gregory S. Cherr, MD², Linda M. Harris, MD², Maciej L. Dryjski, MD 2. ¹SUNY at Buffalo, VA; Western NY Healthcare System, Buffalo, NY, USA, ²SUNY at Buffalo, Buffalo, NY, USA.

24. Quality of Life of Trauma Patients with Vascular Injuries Requiring Revascularization
Eileen DeGrandis, BS, John Blebea, MD, John Wang, Patrick Kelly, RVT, Eugene Palchik, MD. Temple University, Philadelphia, PA, USA.

25. Noninvasive Assessment of Heterogeneous Lower Extremity Perfusion Deficits Using an Emerging Spectroscopic Imaging Technology Before and After Successful Revascularization
Owen N. Johnson, III, MD. , Anton N. Sidawy, MD, MPH, Mark Slidell, MD, MPH, Peter Kreishman, MD,, Roger Walcott, MD, Robyn A. Macsata, MD; Veterans Affairs Medical Center, Washington, DC, USA.

26. Popliteal Artery Injuries in an Urban Trauma Center with a Rural Catchment Area
Jon D. Simmons, MD , Joseph W. Gunter, MD, Fred W. Rushton, Jr., MD, Robert E. Schmieg, Jr., MD, Huey B. McDaniel, MD, Bilski R. Tracy, MD, John M. Porter, MD, Marc E. Mitchell, MD; University of Mississippi, Jackson, MS, USA.

27. Cool Excimer Laser Assisted Angioplasty (CELA) Vs Tibial Balloon Angioplasty (TBA) in Endovascular (EvR)Management of Infragenicular Tibial Arterial Occlusion in Critical Lower Limb Ischaemia (CLI) TASC DE. A Pivotal Observational Analogy Congregate Proportional Analysis 0ver 36 months; Six L Trial.
Wael Tawfick, MB MCh MRCSI, Heba Nashat, MB BCh, Sherif Sultan, MD FRCSI DEVS EBQS – VASC; Western Vascular Institute, Galway, Ireland

MP20. Mechanical SilverHawk Atherectomy as First- Line Stand-Alone Therapy for SFA Lesions
Luis R. Davila-Santini, MD, Feng Qin, MD, Lorena P. DeMarco-Garcia, MD, Julio Calderin, MD, Rajeev Dayal, MD, Toufic K. Safa, MD, Kambhampaty V. Krishnasastry, MD; North Shore-LIJ Health System, New York, NY, USA.

MP21. Single Institution Experience of Initial Participation in a Statewide Multi-Institution Third Party Payer Sponsored Peripheral Vascular Intervention Quality Improvement Initiative
Paul G. Bove, MD , Steven Wang, MD, Terry Bowers, MD; William Beaumont Hospital, Royal Oak, MI, USA.

MP22. Endovascular Training Fellowships: Results of a National Survey
Rabih A. Chaer, MD¹, Daniel Clair, MD², K Craig Kent, MD³ , Kim J. Hodgson, MD⁴ , Edward B. Diethrich, MD⁵ , Pragatheeshwar Thirunavukarasu, MD¹ , Ellen Dillavou, MD¹, Michel S. Makaroun, MD¹; ¹University of Pittsburgh, Pittsburgh, PA, USA, ²Cleveland Clinic Foundation, Cleveland, OH, USA, ³New York Presbyterian Hospital, New York, NY, USA, ⁴Southern Illinois University, Springfield, IL, USA, ⁵Arizona Heart Institute, Phoenix, AZ, USA.

Learning Objectives:
At the completion of this course, the participant will:

• Identify appropriate procedures for aortic endograft duplex surveillance.
• Identify the potential contributions of ultrasound contrast agents.
• Recommend treatment options of pseudoaneurysms and the potential use of thrombin.
• Identify treatment protocols for abdominal visceral imaging and renal artery evaluation as well as the treatment of renal artery stenosis and post stenting evaluation. 
• Identify what velocity elevations post-carotid stenting mean.
• Describe the current status of accreditation and ICAVL. 

Faculty:
“Duplex scanning post carotid stent; What do velocities really mean”
Fred A. Weaver, MD;  Los Angeles, CA

“Aortic Endograft”
Allan M. Dietzek, MD; Danbury, CT

“Ultrasound contrast agents; Will they help”
George H. Meier, MD; Cincinnati, OH

“Thrombin injections; When and when not”
Britt H. Tonnessen, MD; New Orleans, LA

“Abdominal Visceral Imaging”
Leila Mureebe, MD; Durham, NC

“Renal artery evaluation, Renal artery stenosis, and Stenting evaluation”
John Blebea, MD; Philadelphia, PA

“How to work up Venous Insufficiency”
David L. Rollins, MD; Willoughby, OH

“Accreditation; Where are we at”
M. Ashraf Mansour, MD; Grand Rapids, MI

ANNUAL RECEPTION & BANQUET
(Oceanview Terrace)

Registration Desk

Speaker Ready Room

VEIN CASE REPORTS SESSION

SCIENTIFIC SESSION 7 - VISCERAL

Moderated by: Thomas C. Bower, MD & Charles Shanley, MD

Learning Objectives:
• Describe recent trends in outcomes for open and endovascular management of visceral artery obstructive disease
• Recognize evolving treatment planning and technical approaches that may improve outcomes for endovascular treatment of visceral artery obstructive disease
• Identify phenotypic and physiologic factors associated with improved outcomes in patients treated for visceral artery obstructive disease

28. Impact Of Metabolic Syndrome On The Outcomes Of Percutaneous Renal Angioplasty And Stenting
Mark G. Davies, MD PhD MBA , Jean X. Bismuth, MD, Joseph J. Naoum, MD, Imran T. Mouhiddin, MD, Eric K. Peden, MD, Alan B. Lumsden, MD; Methodist Debakey Heart and Vascular Center, Houston, TX, USA.

29. Anatomic Measurements and Factors Associated with Embolic Events during Superior Mesenteric Artery Stenting: Implications for Use of Embolic Protection Devices
Gustavo S. Oderich, MD , Thanila A. Macedo, MD, Rafael Malgor, MD, Joseph J. Ricotta II, MD, Sanjay Misra, MD, Audra A. Duncan, MD, Manju Kalra, MBBS, Peter Gloviczki, MD; Mayo Clinic, Rochester, MN, USA.

MP23. Management of Renal Artery Aneurysms: Surgery, Endovascular Therapy and Observation
Neal S. Cayne, MD , Caron Rockman, MD, Stephen Bauer, MD, Frank Veith, MD, Tom Maldonado, MD, Patrick Lamparello, MD, Mark Adelman, MD, Glenn Jacobowitz, MD, Tom Riles, MD.  NYU Medical Center, New York, NY, USA.

MP24. Outcomes of Endovascular and Open Treatment for Chronic Mesenteric Ischemia
Jeannine Giacovelli, MD, MPH ¹, Alan Dardik, MD, Phd ² , Bart Muhs, MD, PhD ² , Richard Gusberg, MD ² , Bauer Sumpio, MD, PhD ², Jeffrey Indes, MD ². ¹ Columbia University, New York, NY, USA,² Yale University, New Haven, CT, USA.

SESSION ON COMBAT SURGERY

POSTER COMPETITION FINAL ROUND

Moderated by: O. William Brown, MD & Samuel R. Money, MD

Learning Objectives:
• Describe recent trends in outcomes for endovascular management of superficial venous insufficiency
• Recognize evolving treatment planning, technical approaches for endovascular management of venous thromboembolic disease, superficial venous insufficiency and varicose veins
• Identify novel technologies and emerging trends in the management of venous thromboembolic diseas

30. Short Saphenous Vein Radiofrequency Ablation: Is There An Increased Risk of DVT?
Stephen M. Bauer, MD¹, Caron Rockman, MD¹, Jonathon Zagzag, BA², Lowell Kabnick, MD¹, Mark A. Adelman, MD¹; ¹New York University Medical Center, New York, NY, USA, ²New York University School of Medicine, New York, NY, USA.

31. Simultaneous Endochemical And Endovenous Thermal Ablation
Julianne Stoughton, MD, Nancy L. Cantelmo, MD, Sherry Scovell, MD; VeinSolutions, Stoneham, MA, USA.

MP25. Office-Based Minimally Invasive Venous Ablation: The Vascular Group Experience
Stephanie Saltzberg, MD. , Kathleen J. Ozsvath, MD, William J. Byrne, MD, John B. Taggert, MD, Sean P. Roddy, MD, Yaron Sternbach, MD, Manish Mehta, MD, Philip SK Paty, MD, Dhiraj M. Shah, MD, Ralph C. Darling, III, MD; Albany Medical Center, Albany, NY, USA.

MP26. Growing Utilization of IVC Filter Placement from 2001-2005: Analysis of NIS
Peter Lee, MD , Akshay Raizada, MD, Rocco Ciocca, MD; Caritas St. Elizabeth's Medical Center, Boston, MA, USA.

MP27. Percutaneous Thrombolysis for Phlegmasia Cerulea Dolens
Luke S. Erdoes, MD , Jessica B. Ezell, Stuart I. Myers, MD, L Richard Sprouse, Jr., MD, Christopher J. Lesar, MD; University of Tennessee, Chattanooga, TN, USA.